News
ISPC
0.7375
-6.65%
-0.0525
iSpecimen Inc. Announces $400,000 Private Placement of Series D Convertible Preferred Stock
NASDAQ · 23h ago
iSpecimen Announces Series D Preferred Stock Financing
TipRanks · 1d ago
Weekly Report: what happened at ISPC last week (1102-1106)?
Weekly Report · 1d ago
iSpecimen Issues Shares Following Foldlab AI Acquisition
TipRanks · 5d ago
iSpecimen Acquires Two AI Products From Foldlab AI For $4.5M
Benzinga · 5d ago
iSpecimen Expands Into AI-Powered Drug Discovery and Disease Trend Monitoring With Acquisition of Foldlab AI Products
Newsfile · 5d ago
iSpecimen Stockholders Approve Reverse Stock Split Proposal
TipRanks · 11/02 22:49
Weekly Report: what happened at ISPC last week (1026-1030)?
Weekly Report · 11/02 10:10
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 10/30 12:05
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 10/29 21:15
iSpecimen Offers Next-Day Healthy Donor Blood and Launches Development of AI Agent
Newsfile · 10/29 20:10
Weekly Report: what happened at ISPC last week (1019-1023)?
Weekly Report · 10/26 10:10
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/22 12:05
Weekly Report: what happened at ISPC last week (1012-1016)?
Weekly Report · 10/19 10:10
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga · 10/15 21:05
Weekly Report: what happened at ISPC last week (1005-1009)?
Weekly Report · 10/12 10:14
iSpecimen Shareholders Approve Key Financing and Acquisition Actions
TipRanks · 10/09 21:02
Weekly Report: what happened at ISPC last week (0928-1002)?
Weekly Report · 10/05 10:14
iSpecimen Supports Hospital Validation of New Chemistry Analyzer
Newsfile · 09/29 12:05
Weekly Report: what happened at ISPC last week (0921-0925)?
Weekly Report · 09/28 10:09
More
Webull provides a variety of real-time ISPC stock news. You can receive the latest news about Ispecimen Inc. through multiple platforms. This information may help you make smarter investment decisions.
About ISPC
iSpecimen Inc. offers an online marketplace for human biospecimens, connecting scientists in commercial and non-profit organizations with healthcare providers that have access to patients and specimens needed for medical discovery. Proprietary, cloud-based technology enables scientists to intuitively search for specimens and patients across a federated partner network of hospitals, labs, biobanks, blood centers and other healthcare organizations. The Company addresses a critical challenge, which focuses on connecting life science researchers who need human biofluids, tissues, and living cells (biospecimens) for their research. The Company's iSpecimen Marketplace platform is designed to solve this problem and transform the biospecimen procurement process to accelerate medical discovery. The Company, as an AI agent identifies disease-associated proteins and an AI model that predicts and monitors disease trends.